BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1237 related articles for article (PubMed ID: 19397464)

  • 1. Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis.
    Heintz BH; Matzke GR; Dager WE
    Pharmacotherapy; 2009 May; 29(5):562-77. PubMed ID: 19397464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Continuous renal replacement therapies (CRRT) will remain the most widely adopted dialysis modality in the critically ill].
    Morabito S; Pistolesi V; Cibelli L; Pierucci A
    G Ital Nefrol; 2009; 26(1):13-21. PubMed ID: 19255959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy.
    Trotman RL; Williamson JC; Shoemaker DM; Salzer WL
    Clin Infect Dis; 2005 Oct; 41(8):1159-66. PubMed ID: 16163635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent hemodialysis versus continuous renal replacement therapy for acute renal failure in the intensive care unit: an observational outcomes analysis.
    Rauf AA; Long KH; Gajic O; Anderson SS; Swaminathan L; Albright RC
    J Intensive Care Med; 2008; 23(3):195-203. PubMed ID: 18474503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic Dosing for Critically Ill Adult Patients Receiving Intermittent Hemodialysis, Prolonged Intermittent Renal Replacement Therapy, and Continuous Renal Replacement Therapy: An Update.
    Hoff BM; Maker JH; Dager WE; Heintz BH
    Ann Pharmacother; 2020 Jan; 54(1):43-55. PubMed ID: 31342772
    [No Abstract]   [Full Text] [Related]  

  • 6. Economic evaluation of continuous renal replacement therapy in acute renal failure.
    Klarenbach S; Manns B; Pannu N; Clement FM; Wiebe N; Tonelli M;
    Int J Technol Assess Health Care; 2009 Jul; 25(3):331-8. PubMed ID: 19619352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug dosing in continuous renal replacement therapy: general rules.
    Schetz M
    Curr Opin Crit Care; 2007 Dec; 13(6):645-51. PubMed ID: 17975384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of RIFLE classification on prognosis of critically ill patients with acute kidney injury treated with continuous renal replacement therapy.
    Li WX; Chen HD; Wang XW; Zhao S; Chen XK; Zheng Y; Song Y
    Chin Med J (Engl); 2009 May; 122(9):1020-5. PubMed ID: 19493435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute renal failure in critically ill surgical patients: persistent lethality despite new modes of renal replacement therapy.
    Eachempati SR; Wang JC; Hydo LJ; Shou J; Barie PS
    J Trauma; 2007 Nov; 63(5):987-93. PubMed ID: 17993940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Principles of antibacterial dosing in continuous renal replacement therapy.
    Choi G; Gomersall CD; Tian Q; Joynt GM; Freebairn R; Lipman J
    Crit Care Med; 2009 Jul; 37(7):2268-82. PubMed ID: 19487930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival by dialysis modality in critically ill patients with acute kidney injury.
    Cho KC; Himmelfarb J; Paganini E; Ikizler TA; Soroko SH; Mehta RL; Chertow GM
    J Am Soc Nephrol; 2006 Nov; 17(11):3132-8. PubMed ID: 17021268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous renal replacement therapy in the treatment of acute renal failure: critical assessment is required.
    Himmelfarb J
    Clin J Am Soc Nephrol; 2007 Mar; 2(2):385-9. PubMed ID: 17699438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug dosing during continuous renal replacement therapy.
    Churchwell MD; Mueller BA
    Semin Dial; 2009; 22(2):185-8. PubMed ID: 19426426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin versus citrate for anticoagulation in critically ill patients treated with continuous renal replacement therapy.
    Tillman J
    Nurs Crit Care; 2009; 14(4):191-9. PubMed ID: 19531037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino Acid requirements in critically ill patients with acute kidney injury treated with continuous renal replacement therapy.
    Btaiche IF; Mohammad RA; Alaniz C; Mueller BA
    Pharmacotherapy; 2008 May; 28(5):600-13. PubMed ID: 18447659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based renal replacement therapy for acute kidney injury.
    Zarbock A; Singbartl K; Kellum JA
    Minerva Anestesiol; 2009 Mar; 75(3):135-9. PubMed ID: 18475252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosing pattern of renal replacement therapy in acute renal failure: current status and future directions.
    Schiffl H
    Eur J Med Res; 2006 Apr; 11(4):178-82. PubMed ID: 16720285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal replacement therapy in acute kidney injury: which method to use in the intensive care unit?
    Davenport A
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):529-36. PubMed ID: 18580008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of renal replacement therapy in critically ill patients with acute kidney injury.
    Bouman CS; Oudemans-van Straaten HM
    Curr Opin Crit Care; 2007 Dec; 13(6):656-61. PubMed ID: 17975386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosing of daptomycin in intensive care unit patients with acute kidney injury undergoing extended dialysis--a pharmacokinetic study.
    Kielstein JT; Eugbers C; Bode-Boeger SM; Martens-Lobenhoffer J; Haller H; Joukhadar C; Traunmüller F; Knitsch W; Hafer C; Burkhardt O
    Nephrol Dial Transplant; 2010 May; 25(5):1537-41. PubMed ID: 20031929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.